ArticleJournal of clinical medicine2023

Nebulized Recombinant Tissue Plasminogen Activator (rt-PA) for Acute COVID-19-Induced Respiratory Failure: An Exploratory Proof-of-Concept Trial.

Pratima Chowdary et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.